<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">101235741</journal-id>
<journal-id journal-id-type="pubmed-jr-id">32200</journal-id>
<journal-id journal-id-type="nlm-ta">Am J Med Genet A</journal-id>
<journal-id journal-id-type="iso-abbrev">Am. J. Med. Genet. A</journal-id>
<journal-title-group>
<journal-title>American journal of medical genetics. Part A</journal-title>
</journal-title-group>
<issn pub-type="ppub">1552-4825</issn>
<issn pub-type="epub">1552-4833</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30556641</article-id>
<article-id pub-id-type="pmc">6347555</article-id>
<article-id pub-id-type="doi">10.1002/ajmg.a.60681</article-id>
<article-id pub-id-type="manuscript">NIHMS995107</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Newborn screening for Prader-Willi syndrome is feasible: Early diagnosis for better outcomes</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Mahmoud</surname>
<given-names>Ranim</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Singh</surname>
<given-names>Preeti</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Weiss</surname>
<given-names>Lan</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lakatos</surname>
<given-names>Anita</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Oakes</surname>
<given-names>Melanie</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hossain</surname>
<given-names>Waheeda</given-names>
</name>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Butler</surname>
<given-names>Merlin G.</given-names>
</name>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kimonis</surname>
<given-names>Virginia</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Department of Pediatrics, Division of Genetics and Metabolism, University of California, Irvine, CA</aff>
<aff id="A2"><label>2</label>Department of Pediatrics, Genetics Unit, Faculty of Medicine, Mansoura University, Mansoura, Egypt</aff>
<aff id="A3"><label>3</label>Department of Pediatrics, Division of Neonatology, University of California, Irvine, CA</aff>
<aff id="A4"><label>4</label>Genomics High Throughput Facility, University of California, Irvine, CA</aff>
<aff id="A5"><label>5</label>Departments of Psychiatry, Behavioral Sciences, and Pediatrics, Kansas University Medical Center, Kansas City, KS</aff>
<author-notes>
<corresp id="CR1"><label>*</label>Correspondence: Virginia Kimonis, MD, Professor of Pediatrics, Division of Genetics &amp; Genomic Medicine, University of California-Irvine, Irvine, California, Phone: (949) 824-0571, Fax: (949) 824-0171, <email>vkimonis@uci.edu</email></corresp>
<corresp id="CR2">Merlin G. Butler, MD, PhD, Departments of Psychiatry &amp; Behavioral Sciences and Pediatrics, Kansas University Medical Center, 3901 Rainbow Boulevard, MS 4015, Kansas City, Kansas 66160, Phone: (913) 588-1800, Fax: (913) 588-1305, <email>mbutler4@kumc.edu</email></corresp>
<fn fn-type="COI-statement" id="FN1">
<p id="P28">The authors claim no conflict of interest.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>30</day>
<month>10</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>17</day>
<month>12</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<month>1</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>1</month>
<year>2020</year>
</pub-date>
<volume>179</volume>
<issue>1</issue>
<fpage>29</fpage>
<lpage>36</lpage>
<!--elocation-id from pubmed: 10.1002/ajmg.a.60681-->
<abstract id="ABS1">
<sec id="S1">
<title>Introduction:</title>
<p id="P1">Prader-Willi syndrome (PWS), is a complex genetic disease affecting 1/15,000 individuals, characterized by lack of expression of genes on the paternal chromosome 15q11-q13 region. Clinical features include central hypotonia, poor suck, learning and behavior problems, growth hormone deficiency with short stature, hyperphagia and morbid obesity. Despite significant advances in genetic testing, the mean age for diagnosis in PWS continues to lag behind.</p>
</sec>
<sec id="S2">
<title>Objective:</title>
<p id="P2">Our goal was to perform a pilot feasibility study to confirm the diagnosis utilizing different genetic technologies in a cohort of 34 individuals with genetically confirmed PWS and 16 healthy controls from blood samples spotted and stored on newborn screening (NBS) filter paper cards.</p>
</sec>
<sec id="S3">
<title>Methods:</title>
<p id="P3">DNA was isolated from NBS cards, and PWS testing performed using DNA methylation-specific PCR (mPCR<bold>)</bold> and the MS-MLPA chromosome 15 probe kit followed by DNA fragment analysis for methylation and copy number status.</p>
</sec>
<sec id="S4">
<title>Results:</title>
<p id="P4">DNA extraction was successful in 30 of 34 PWS patients and 16 controls. PWS methylation testing was able to correctly identify all PWS patients and MS-MLPA was able to differentiate between 15q11-q13 deletion and non-deletion status and correctly identify deletion subtype (i.e., larger Type I or smaller Type II).</p>
</sec>
<sec id="S5">
<title>Conclusion:</title>
<p id="P5">mPCR can be used to diagnose PWS and MS-MLPA testing to determine both methylation status as well as the type of deletion or non-deletion status from DNA extracted from NBS filter paper. We propose that PWS testing in newborns is possible and could be included in the Recommended Uniform Screening Panel after establishing a validated cost-effective method.</p>
</sec>
</abstract>
<kwd-group>
<kwd>Prader-Willi syndrome</kwd>
<kwd>newborn screening</kwd>
<kwd>DNA methylation</kwd>
<kwd>MLPA (Multiplex Ligand PCR Analysis)</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>